Novelix Pharmaceuticals Ltd — Important, 11-12-2025: Company Update

Novelix Pharmaceuticals' board has decided to raise fresh capital by issuing 2.5 Cr equity shares. These shares will be allotted on a preferential basis to a mix of Promoter/Promoter Group and Non-Promoters at Rs. 60 per share, totaling Rs. 15 Cr. This strategic move aims to bolster the company's financial resources for operational expansion and future initiatives. The issuance is subject to shareholder approval, indicating a potential shift in ownership structure and capital base.